Specifically, full-body expression of CAG-promoter-driven levels of human A3B, which approximate those in human tumors, results in accelerated rates of B cell lymphomagenesis and hepatocellular carcinogenesis as well as a smaller number of other tumor types. The gene discussed is APOBEC3B; the disease is neoplasm.